© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, Kalaris Therapeutics Inc (KLRS) shows an Average True Range (ATR) of 0.98 and an Enterprise Value of N/A. Its average trading volume over the past 3 months is 169.58K, indicating liquidity. These fundamental metrics provide insight into KLRS's underlying financial health and market activity.
Kalaris Therapeutics Inc (KLRS) technical indicators as of December 23, 2025: the SMA 20 is 35.13%, SMA 50 at 65.71%, and SMA 200 at 101.04%. The RSI 14 value is 69.18, suggesting its current momentum. These technical analysis signals help assess KLRS's price trends and potential future movements.
Kalaris Therapeutics Inc (KLRS) stock performance overview as of December 23, 2025: The 52-week high is $12.78 (currently -22.02% below), and the 52-week low is $2.14 (currently 370.09% above). Over the past year, KLRS's performance is N/A, compared to the S&P 500's 10.56% change.
According to market data, Kalaris Therapeutics Inc (KLRS) stock's recent performance metrics show that over the last month, KLRS is 50.6%, with a Year-to-Date (YTD) performance of N/A. Over the past year, the stock has seen a N/A change. These figures summarize KLRS's price movements across various periods, reflecting its historical returns.
According to current financial data, KLRS stock's P/E (TTM) ratio is -3.49, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for KLRS, including P/S (N/A), P/B (4.32), and P/FCF (-4.73), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.